Data / Form D filings / Alpheus Medical, Inc.
Alpheus Medical, Inc.: Form D filings
Alpheus Medical, Inc., a biotechnology company in Chanhassen, MN, filed 11 Form D notices with the SEC between 2017 and 2026. The latest, on July 30, 2026, reports $60.5 million sold of a $67 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1266 Park Road, Chanhassen, MN, 55317
- Phone
- (310) 413-4338
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1716636
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Amendment | $66,977,409 | $60,477,409 | $6,500,000 | 22 | May 2, 2025 | sec.gov |
| May 19, 2025 | New notice | $60,477,409 | $34,527,457 | $25,949,952 | 22 | May 2, 2025 | sec.gov |
| Nov 9, 2022 | New notice | $13,999,995 | $13,999,995 | 4 | Oct 25, 2022 | sec.gov | |
| Dec 23, 2020 | New notice | $16,000,000 | $6,000,000 | $10,000,000 | 23 | Dec 16, 2020 | sec.gov |
| May 1, 2020 | Amendment | $700,000 | $519,000 | $181,000 | 12 | Oct 4, 2019 | sec.gov |
| Oct 15, 2019 | New notice | $300,000 | $50,000 | $250,000 | 2 | Oct 4, 2019 | sec.gov |
| Oct 29, 2018 | Amendment | $1,300,000 | $1,284,005 | $15,995 | 22 | Apr 25, 2018 | sec.gov |
| May 2, 2018 | New notice | $1,000,000 | $642,873 | $357,127 | 5 | Apr 25, 2018 | sec.gov |
| Mar 28, 2018 | Amendment | $150,000 | $150,000 | 2 | Jan 21, 2018 | sec.gov | |
| Jan 25, 2018 | New notice | $150,000 | $100,000 | $50,000 | 1 | Jan 21, 2018 | sec.gov |
| Sep 11, 2017 | New notice | $300,000 | $225,000 | $75,000 | 2 | May 24, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vijay Agarwal | Executive Officer, Director | |
| Jeremy Ling | Executive Officer | |
| Imran Eba | Executive Officer | |
| John Johnson | Director | |
| Robert Stein | Director | |
| Juan-Pablo Mas | Director | |
| Peter Thompson | Director | |
| Klaus Veitinger | Director | |
| Steve Weiner | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jul 27, 2026 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alpheus Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.